MARK-B COVID-19 Test is a electrochemical immunoassay test designed for the qualitative presumptive detection in human fluid.
Fast results within 20 mins
Specimen : whole blood, serum, nasopharyngeal swab
Contact : firstname.lastname@example.org
Fully automated analysis
Once inserted into the instrument, the sample is separated into plasma by our patent technology.
In succession, the electrochemical analysis process begins.
No need for pre-processing
Quick turnaround 20mins
by electrochemical method
MARK-B utilizes MESIA,
a patented technology of BBB inc.
Published Journal Paper
“MESIA: Magnetic force-assisted electrochemical sandwich immunoassays for quantification of prostate-specific antigen in human serum”
- <Analytica Chimica Acta>, March, 2019
_ PhD. Hyundoo Hwang, Leader of BBB R&D Center
High expandability in test portfolio
*Not available for sale
*Scheduled to release in 2020
Cloud server to communicate with MARK-B test results
POCT1-A2 protocol, HL7, FHIR® to communicate with DMS
Android based Analyzer software
**Depends on the analyte